Onsets of progression and second treatment determine survival of patients with symptomatic Waldenström macroglobulinemia

Few reports assess prognosis during follow-up of patients with symptomatic Waldenström macroglobulinemia (WM). In 121 WM patients treated between 1993 and 2016, we analyzed the prognostic role during the clinical course of the initial International Prognostic Scoring System for WM (IPSSWM). Then, we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood Adv
Hauptverfasser: Guidez, Stephanie, Labreuche, Julien, Drumez, Elodie, Ysebaert, Loic, Bakala, Jana, Delette, Caroline, Hivert, Bénédicte, Protin, Caroline, Declercq, Hervé, Verlay, Mélanie, Marolleau, Jean Pierre, Duhamel, Alain, Morel, Pierre
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2018
Schlagworte:
Clinical Trials and Observations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6258926/
https://ncbi.nlm.nih.gov/pubmed/30455359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018021287
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge